This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (458K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Arnold K, Gerber N. The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):121–134.[PubMed]
BUTLER TC. The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin. J Pharmacol Exp Ther. 1957 Jan;119(1):1–11.[PubMed]
Kemp JW, Woodbury DM. Subcellular distribution of 4- 14 C-diphenylhydantoin in rat brain. J Pharmacol Exp Ther. 1971 May;177(2):342–349.[PubMed]
Lund L, Berlin A, Lunde KM. Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluid. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):196–200.[PubMed]
Lunde PK, Rane A, Yaffe SJ, Lund L, Sjöqvist F. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution. Clin Pharmacol Ther. 1970 Nov-Dec;11(6):846–855.[PubMed]
O'Doherty DS, O'Malley WE, Denckla MB. Oral absorption of diphenylhydantoin as measured by gas liquid chromatography. Trans Am Neurol Assoc. 1969;94:318–319.[PubMed]
Rizzo M, Morselli PL, Garattini S. Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat. Biochem Pharmacol. 1972 Feb 15;21(4):449–454.[PubMed]
WADDELL WJ, BUTLER TC. The distribution and excretion of phenobarbital. J Clin Invest. 1957 Aug;36(8):1217–1226.[PMC free article][PubMed]
WERK EE, Jr, MACGEE J, SHOLITON LJ. EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN. J Clin Invest. 1964 Sep;43:1824–1835.[PMC free article][PubMed]
ANKENMAN GJ, BALFOUR J. Atonic neurogenic bladder as a manifestation of diabetic neuropathy. J Urol. 1956 Dec;76(6):746–752.[PubMed]
Bartley O, Brolin I, Fagerberg SE, Wilhelmsen L. Neurogenic disorders of the bladder in diabetes mellitus. A clinical-roentgenological investigation. Acta Med Scand. 1966 Aug;180(2):187–198.[PubMed]
Bates CP. Continence and incontinence. A clinical study of the dynamics of voiding and of the sphincter mechanism. Ann R Coll Surg Engl. 1971 Jul;49(1):18–35.[PMC free article][PubMed]
Brown M, Wickham JE. The urethral pressure profile. Br J Urol. 1969 Apr;41(2):211–217.[PubMed]
Faerman I, Maler M, Jadzinsky M, Alvarez E, Fox D, Zilbervarg J, Cibeira JB, Colinas R. Asymptomatic neurogenic bladder in juvenile diabetics. Diabetologia. 1971 Jun;7(3):168–172.[PubMed]
LARCAN A, HURIET C, VAILLANDET M, FAUCHIER JP. LES MANIFESTATIONS V'ESICALES AU COURS DU DIAB'ETE. INT'ER ET DE LA CYSTOMANOM'ETRIE. Presse Med. 1965 Jan 30;73:273–276.[PubMed]
Roy RR. A direct reading uroflowmeter for male and female use. Br J Urol. 1971 Apr;43(2):239–242.[PubMed]
SPRING M, HYMES J. Neurogenic bladder dysfunction as a complication of diabetes; report of seven cases. Diabetes. 1953 May-Jun;2(3):199–205.[PubMed]
VON GARRELTS B. Analysis of micturition; a new method of recording the voiding of the bladder. Acta Chir Scand. 1957 Mar 28;112(3-4):326–340.[PubMed]
Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press